Elanco Animal Health Pre-Tax Profit Margin 2016-2025 | ELAN
Current and historical pre-tax profit margin for Elanco Animal Health (ELAN) from 2016 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Elanco Animal Health pre-tax profit margin for the three months ending September 30, 2025 was .
| Elanco Animal Health Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-09-30 | $4.59B | $-0.02B | -0.35% |
| 2025-06-30 | $4.48B | $0.59B | 13.22% |
| 2025-03-31 | $4.43B | $0.54B | 12.11% |
| 2024-12-31 | $4.44B | $0.49B | 10.99% |
| 2024-09-30 | $4.45B | $0.41B | 9.25% |
| 2024-06-30 | $4.49B | $-1.24B | -27.69% |
| 2024-03-31 | $4.37B | $-1.29B | -29.58% |
| 2023-12-31 | $4.42B | $-1.20B | -27.05% |
| 2023-09-30 | $4.37B | $-1.16B | -26.50% |
| 2023-06-30 | $4.32B | $-0.10B | -2.41% |
| 2023-03-31 | $4.44B | $-0.04B | -0.88% |
| 2022-12-31 | $4.41B | $-0.07B | -1.63% |
| 2022-09-30 | $4.54B | $-0.11B | -2.38% |
| 2022-06-30 | $4.64B | $-0.19B | -4.18% |
| 2022-03-31 | $4.75B | $-0.42B | -8.76% |
| 2021-12-31 | $4.76B | $-0.57B | -11.99% |
| 2021-09-30 | $4.79B | $-0.77B | -16.06% |
| 2021-06-30 | $4.55B | $-0.85B | -18.65% |
| 2021-03-31 | $3.86B | $-0.69B | -17.87% |
| 2020-12-31 | $3.27B | $-0.68B | -20.70% |
| 2020-09-30 | $2.92B | $-0.36B | -12.29% |
| 2020-06-30 | $2.80B | $-0.16B | -5.82% |
| 2020-03-31 | $3.00B | $-0.04B | -1.20% |
| 2019-12-31 | $3.07B | $0.08B | 2.51% |
| 2019-09-30 | $3.08B | $0.08B | 2.59% |
| 2019-06-30 | $3.07B | $0.17B | 5.60% |
| 2019-03-31 | $3.06B | $0.08B | 2.68% |
| 2018-12-31 | $3.07B | $0.12B | 3.75% |
| 2018-06-30 | $2.20B | $0.03B | 1.32% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $12.377B | $4.439B |
| Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quest Diagnostics (DGX) | United States | $20.264B | 18.86 |
| Encompass Health (EHC) | United States | $9.998B | 19.22 |
| DaVita (DVA) | United States | $7.707B | 11.26 |
| Chemed (CHE) | United States | $6.299B | 22.13 |
| Option Care Health (OPCH) | United States | $5.808B | 24.72 |
| RadNet (RDNT) | United States | $5.629B | 192.03 |
| LifeStance Health (LFST) | United States | $2.867B | 0.00 |
| Addus HomeCare (ADUS) | United States | $2.040B | 21.06 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.863B | 23.47 |
| Astrana Health (ASTH) | United States | $1.554B | 145.26 |
| U.S Physical Therapy (USPH) | United States | $1.330B | 33.64 |
| Pennant (PNTG) | United States | $1.078B | 35.82 |
| Daxor (DXR) | United States | $0.066B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.049B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |